Article

Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble…

medRxiv · 2022 · Ann-Kathrin Mattes

Key facts

Title Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cells
First author Ann-Kathrin Mattes
Journal medRxiv
Published Aug 27, 2022
DOI 10.1101/2022.08.26.505456
Devices mentioned BK110039, DEN000008, K022086, K103302, K123955, K852441, K854177, K854178, K854179, K854180, K854181, K854182 and 6 more
Product codes mentioned JCI, KIP, KIT, MVU, NDS, NJT, OOI, PFF, PFT, PCA

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature